The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
D000818:Animals; D000936:Antigen-Antibody Complex; D001201:Ascites; D002606:Charcoal; D004077:Digoxin / Q000097:blood* / Q000276:immunology; D006207:Half-Life; D006801:Humans; D007106:Immune Sera; D007664:Ketosteroids / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D011245:Pregnadienes / Q000494:pharmacology*; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay / Q000379:methods*; D012756:Sheep / Q000276:immunology; D013148:Spironolactone / Q000494:pharmacology*; D014316:Tritium
D000936:Antigen-Antibody Complex; D007106:Immune Sera; D007664:Ketosteroids; D007783:Lactones; D011245:Pregnadienes; D014316:Tritium; D002606:Charcoal; D013148:Spironolactone; D004077:Digoxin